Literature DB >> 17284529

Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria.

Lucia Gargiulo1, Sonia Lastraioli, Giannamaria Cerruti, Martina Serra, Fabrizio Loiacono, Simona Zupo, Lucio Luzzatto, Rosario Notaro.   

Abstract

Deficiency of glycosylphosphatidylinositol (GPI)-anchored molecules on blood cells accounts for most features of paroxysmal nocturnal hemoglobinuria (PNH) but not for the expansion of PNH (GPI(-)) clone(s). A plausible model is that PNH clones expand by escaping negative selection exerted by autoreactive T cells against normal (GPI(+)) hematopoiesis. By a systematic analysis of T-cell receptor beta (TCR-beta) clonotypes of the CD8+ CD57+ T-cell population, frequently deranged in PNH, we show recurrent clonotypes in PNH patients but not in healthy controls: 11 of 16 patients shared at least 1 of 5 clonotypes, and a set of closely related clonotypes was present in 9 patients. The presence of T-cell clones bearing a set of highly homologous TCR-beta molecules in most patients with hemolytic PNH is consistent with an immune process driven by the same (or similar) antigen(s)-probably a nonpeptide antigen, because patients sharing clonotypes do not all share identical HLA alleles. These data confirm that CD8+ CD57+ T cells play a role in PNH pathogenesis and provide strong new support to the hypothesis that the expansion of the GPI(-) blood cell population in PNH is due to selective damage to normal hematopoiesis mediated by an autoimmune attack against a nonpeptide antigen(s) that could be the GPI anchor itself.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284529     DOI: 10.1182/blood-2006-10-052381

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes: clonal expansion of PIG-A-mutant hematopoietic cells in bone marrow failure.

Authors:  Neal S Young
Journal:  Haematologica       Date:  2009-01       Impact factor: 9.941

Review 2.  Inflammatory bone marrow microenvironment.

Authors:  Nils B Leimkühler; Rebekka K Schneider
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  A paroxysmal nocturnal haemoglobinuria progress with waldenström macroglobulinemia along with T cell monoclonal expansion.

Authors:  Hongying Liu; Chuan He; Huanling Zhu; Xianglong Li; Chunli Yang; Dewan Zhao; Xiujin Wu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-24       Impact factor: 0.900

4.  Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells.

Authors:  Xin Zhao; Shouguo Gao; Zhijie Wu; Sachiko Kajigaya; Xingmin Feng; Qingguo Liu; Danielle M Townsley; James Cooper; Jinguo Chen; Keyvan Keyvanfar; Maria Del Pilar Fernandez Ibanez; Xujing Wang; Neal S Young
Journal:  Blood       Date:  2017-10-13       Impact factor: 22.113

Review 5.  Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

Review 6.  Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; Antonio M Risitano; John D Lambris
Journal:  Semin Hematol       Date:  2018-02-14       Impact factor: 3.851

Review 7.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

8.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

Review 9.  Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; Despina Yancopoulou; Antonio Risitano; John D Lambris
Journal:  Expert Rev Hematol       Date:  2014-09-02       Impact factor: 2.929

10.  Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells.

Authors:  Valeria Visconte; Nalini Raghavachari; Delong Liu; Keyvan Keyvanfar; Marie J Desierto; Jichun Chen; Neal S Young
Journal:  Haematologica       Date:  2009-08-13       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.